All information is correct at the time of publication.
Date published: 29 January 2024
Click on the links in the age groups for more information about the disease each vaccine protects against.
8 weeks old:
12 weeks old:
16 weeks old:
12 to 13 months old:
2 to 3 years old and all school-aged children:
3 years and 4 months old:
School year 8 (12 to 13 years old):
School year 9 (13 and 14 years old):
Age 65 and older:
65 years and 70 to 79 years old (plus individuals from age 50 who are severely immunosuppressed)
| Age due | Diseases protected against | Vaccine and name | Usual site1 | |
|---|---|---|---|---|
|
8 weeks old |
Diphtheria, tetanus, pertussis (whooping cough), polio, haemophilus influenzae type b (Hib) and hepatitis B |
DTaP/IPV/Hib/ HepB |
Infanrix hexa or Vaxelis |
Thigh |
|
Meningococcal group B (MenB) |
MenB |
Bexsero |
Left thigh |
|
|
Rotavirus gastroenteritis |
Rotavirus |
Rotarix |
By mouth |
|
| 12 weeks old | Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B | DTaP/IPV/Hib/ HepB | Infanrix hexa or Vaxelis | Thigh |
| Pneumococcal (13 serotypes) | PCV | Prevenar 13 | Thigh | |
| Rotavirus gastroenteritis | Rotavirus | Rotarix | By mouth | |
|
16 weeks old |
Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B | DTaP/IPV/Hib/ HepB | Infanrix hexa or Vaxelis | Thigh |
| Meningococcal group B | MenB | Bexsero | Left thigh | |
| 12-13 months old | Hib / Meningococcal group C | Hib/MenC | Menitorix | Upper arm/ thigh |
| Pneumococcal | PCV booster | Prevenar 13 | Upper arm/ thigh | |
| Measles, mumps and rubella | MMR | MMRVaxPRO or Priorix | Upper arm/ thigh | |
| Meningococcal group B | MenB booster | Bexsero | Left thigh | |
| 22 and 3 years old and all school aged children | Influenza (annually from September) | Live attenuated influenza vaccine | Fluenz Tetra3 | Both nostrils |
| 3 years 4 months old | Diphtheria, tetanus, pertussis and polio | dTaP/IPV | Boostrix-IPV | Upper arm |
| Measles, mumps and rubella | MMR | MMRVaxPRO or Priorix | Upper arm | |
| School year 8 (12 to 13 year olds) |
Cervical cancer, some head and neck and ano-genital cancers, and genital warts caused by human papillomavirus (HPV) | HPV4 (one dose) | Gardasil 9 | Upper arm |
| School year 9 (13 and 14 year olds) |
Tetanus, diphtheria and polio | Td/IPV (check MMR status) | Revaxis | Upper arm |
| Meningococcal groups A, C, W and Y | MenACWY | Nimenrix | Upper arm | |
| 65 years of age and older | Influenza (annually from September) | Inactivated influenza vaccine | Multiple | Upper arm |
| Pneumococcal (23 serotypes) | Pneumococcal polysaccharide vaccine (PPV) | Pneumovax 23 | Upper arm | |
| 65 years and 70 to 79 years old (plus individuals from age 50 who are severely immunosuppressed)5 | Shingles | Shingles | Zostavax6 (one dose) or Shingrix7 (two doses) |
Upper arm |
1 Where two or more injections are required at once, these should ideally be given in different limbs. Where this is not possible, injections in the same limb should be given 2.5cm apart. For more details see Chapters 4 and 11 in the Green Book. All injected vaccines are given intramuscularly unless stated otherwise.
2 Children must be 2 years old by 31 August to receive influenza vaccine in the routine programme in autumn/winter.
3 If Fluenz Tetra is contraindicated, use a suitable inactivated flu vaccine.
4 Check the relevant chapter of the Green Book for individuals requiring a 3 dose schedule.
5 Zostavax is contraindicated in those with severe immunosuppression. See Green Book Chapter 28a Shingles for further details and definition of severe immunosuppression.
6 Those previously eligible for Zostavax will be offered Zostavax until supply is depleted. Zostavax is contraindicated in those with severe immunosuppression. Please refer to Green Book Chapter 28a for further details.
7 Immunocompetent individuals require two doses of Shingrix with the second dose given 6 to 12 months after the first dose. Immunosuppressed individuals require two doses with the second dose given 8 weeks to 6 months after the first dose.
| Target group | Age and schedule | Disease | Vaccines |
|---|---|---|---|
| Babies born to hepatitis B infected mothers |
At birth and 1 month old. |
Hepatitis B | Hepatitis B vaccines (Engerix B / HBVaxPRO) |
| Infants in areas of the country with TB incidence >= 40/100,000 | At birth | Tuberculosis | BCG |
| Infants with a parent or grandparent born in a high incidence country2 | At birth | Tuberculosis | BCG |
| People in a risk group for influenza | From 6 months to 64 years | Influenza | LAIV for children aged 2-17 years. Inactivated flu vaccine for other ages or if LAIV contraindicated |
| Additional groups eligible for a flu vaccine3 | During flu season | Influenza | Inactivated flu vaccine |
| Pregnant women | From 16 weeks of pregnancy | Pertussis | dTaP/IPV (Boostrix-IPV) |
| Gay, bisexual and other men who have sex with men | HPV6 | Gardasil 9 |
1 In addition to hexavalent vaccine (Infanrix hexa or Vaxelis) given at 8, 12 and 16 weeks. Take blood for HBsAg to exclude infection at 12/13 months.
2 Where the annual incidence of TB is >= 40/100,000 see www.gov.uk/government/publications/tuberculosis-tb-by-country-rates-per-100000-people.
3 Refer to annual flu Welsh Health Circular (WHC) for eligibility.
4 1 dose.
5 2 doses 6-24 months apart.
6 Check the relevant chapter of the Green Book for individuals requiring a 3 dose schedule
| Medical condition | Diseases protected against | Vaccines required2 |
|---|---|---|
| Asplenia or splenic dysfunction (including sickle cell and coeliac disease) | Meningococcal groups A, B, C, W and Y Pneumococcal Influenza |
MenACWY MenB PCV13 (up to ten years of age)3 PPV (from two years of age) Annual flu vaccine4 |
| Cochlear implants, cerebrospinal fluid leaks | Pneumococcal | PCV13 (up to ten years of age)3 PPV (from two years of age) |
| Chronic respiratory and heart conditions (such as moderate to severe asthma, chronic pulmonary disease, and heart failure) |
Pneumococcal Influenza |
PCV13 (up to ten years of age)3 PPV (from two years of age) Annual flu vaccine4 |
| Chronic neurological conditions (such as Parkinson’s or motor neurone disease, or learning disability) |
Pneumococcal Influenza |
PCV13 (up to ten years of age)3 PPV (from two years of age) Annual flu vaccine4 |
| Diabetes | Pneumococcal Influenza |
PCV13 (up to ten years of age)3 PPV (from two years of age) Annual flu vaccine4 |
|
Chronic kidney disease (CKD) |
Pneumococcal (stage 4 and 5 CKD) Influenza (stage 3, 4 and 5 CKD) Hepatitis B (stage 4 and 5 CKD) |
PCV13 (up to ten years of age)3 PPV (from two years of age) Annual flu vaccine4 Hepatitis B |
| Chronic liver conditions | Pneumococcal Influenza Hepatitis A & B |
PCV13 (up to ten years of age)3 PPV (from two years of age) Annual flu vaccine4 Hepatitis A & Hepatitis B |
| Haemophilia | Hepatitis A & B | Hepatitis A & Hepatitis B |
| Complement disorders (including those receiving complement inhibitor therapy) | Meningococcal groups A, B, C, W and Y Pneumococcal Influenza |
MenACWY |
| Immunosuppression due to disease or treatment | Pneumococcal Influenza Shingles |
PCV13 (up to ten years of age)3, 5 PPV (from two years of age) Annual flu vaccine4 Shingrix (aged 50 years and over)6 |
1 The list is not exhaustive. Other vaccines may be recommended for certain individuals.
2 Check relevant chapter of Green Book for specific schedule and for further detail.
3 If aged two years to under ten years of age and unimmunised or partially immunised against pneumococcal infection, give one PCV13 dose.
4 From six months of age.
5 To any age in severe immunosuppression. Check relevant chapter of Green Book for specific schedule and for further detail.
6 Check Green Book Chapter 28a: Shingles for definition of severe immunosuppression and interval for second dose.